Genome-wide ENU mutagenesis screen for Runx2 modifiers
Runx2 修饰符的全基因组 ENU 诱变筛选
基本信息
- 批准号:6956298
- 负责人:
- 金额:$ 9.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-01 至 2006-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of our project is to identify factors regulating mesenchymal cells commitment and early maturation into differentiated osteoblasts. As a first step toward this goal, we propose to perform a genome-wide genetic screen in mice using ethyl-nitrosourea (ENU) mutagenesis to expose mutations able to functionally compensate for Runx2 haploinsufficiency. Runx2 is the earliest known determinant of osteoblast differentiation, and loss of one Runx2 allele in mice or human causes Cleidocranial dysplasia (CCD), a skeletal disorder marked by clavicle agenesis and ossification defects. Any regulator of Runx2 expression or activity is thus likely to be involved in controlling either osteoblast differentiation or osteoblast function. Our strategy relies on a search for ENU-mutated animals that harbor a rescued CCD phenotype despite a Runx2 genetic background. We hypothesize that such rescuing mutations will affect regulators of Runx2 gene expression or protein stability/availability/activity or trigger yet unknown parallel or downstream compensating pathways. Subsequent characterization of the genes harboring these mutations should thus identify regulators involved in the early steps of skeletogenesis. The present application proposes to identify rescued Runx2 ENU mutants and to select the best candidates for subsequent mutation mapping and gene identification. Our specific aims are: to identify ENU-mutated mouse strains harboring a rescue of the CCD phenotype despite heterozygocity at the Runx2 locus; and to compare the mutant lines isolated and prioritize them for subsequent mutation mapping.
描述(由申请人提供):我们项目的长期目标是确定调节间充质细胞承诺和分化成骨细胞的早期成熟的因素。作为实现这一目标的第一步,我们建议使用乙基亚硝胺(ENU)突变对小鼠进行全基因组遗传筛查,以揭示能够在功能上补偿Runx2单倍体不足的突变。Runx2是已知的最早的成骨细胞分化决定因素,在小鼠或人类中,Runx2等位基因缺失会导致锁骨颅骨发育不良(CCD),这是一种以锁骨发育不全和骨化缺陷为特征的骨骼疾病。因此,Runx2表达或活性的任何调节因子都可能参与控制成骨细胞分化或成骨细胞功能。我们的策略依赖于寻找ENU突变的动物,这些动物具有挽救的CD表型,尽管有Runx2的遗传背景。我们推测,这种救助性突变将影响Runx2基因表达或蛋白质稳定性/可用性/活性的调节,或触发未知的平行或下游补偿途径。因此,随后对含有这些突变的基因的特征应该确定与骨骼形成的早期步骤有关的调节因子。本申请建议鉴定挽救的Runx2 ENU突变体,并为随后的突变作图和基因鉴定选择最佳候选者。我们的具体目标是:鉴定ENU突变的小鼠品系,尽管Runx2基因座为杂合子,但仍具有挽救Ccd表型的能力;并比较分离的突变株,并将它们优先用于后续的突变图谱。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patricia Florence Ducy其他文献
Patricia Florence Ducy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patricia Florence Ducy', 18)}}的其他基金
Cross-talk between skeleton and pancreas morphogeneses during development
发育过程中骨骼和胰腺形态发生之间的串扰
- 批准号:
8806907 - 财政年份:2015
- 资助金额:
$ 9.75万 - 项目类别:
Impact of gonadal failure on the bone-mediated regulation of glucose metabolism
性腺衰竭对骨介导的葡萄糖代谢调节的影响
- 批准号:
10417244 - 财政年份:2010
- 资助金额:
$ 9.75万 - 项目类别:
Impact of gonadal failure on the bone-mediated regulation of glucose metabolism
性腺衰竭对骨介导的葡萄糖代谢调节的影响
- 批准号:
10024565 - 财政年份:2010
- 资助金额:
$ 9.75万 - 项目类别:
Impact of gonadal failure on the bone-mediated regulation of glucose metabolism
性腺衰竭对骨介导的葡萄糖代谢调节的影响
- 批准号:
10254402 - 财政年份:2010
- 资助金额:
$ 9.75万 - 项目类别:
Impact of gonadal failure on the bone-mediated regulation of glucose metabolism
性腺衰竭对骨介导的葡萄糖代谢调节的影响
- 批准号:
10632051 - 财政年份:2010
- 资助金额:
$ 9.75万 - 项目类别:
相似国自然基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现
- 批准号:41606166
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Screen molecules modulating MOR trafficking with a newly developed MOR/14-3-3 bioassay.
使用新开发的 MOR/14-3-3 生物测定法筛选调节 MOR 运输的分子。
- 批准号:
9900303 - 财政年份:2019
- 资助金额:
$ 9.75万 - 项目类别:
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.
图像引导胰腺神经内分泌肿瘤的药物输送。
- 批准号:
9302133 - 财政年份:2017
- 资助金额:
$ 9.75万 - 项目类别:
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.
图像引导胰腺神经内分泌肿瘤的药物输送。
- 批准号:
9566182 - 财政年份:2017
- 资助金额:
$ 9.75万 - 项目类别:
Translational Control of Radiation-Induced Apoptosis
辐射诱导细胞凋亡的转化控制
- 批准号:
7059786 - 财政年份:2009
- 资助金额:
$ 9.75万 - 项目类别:
Development of Superagonist Analogs of Recombinant Human TSH
重组人 TSH 超级激动剂类似物的开发
- 批准号:
7108446 - 财政年份:2006
- 资助金额:
$ 9.75万 - 项目类别:
Database for Modified Nucleotides, Fluorophors and Additives
修饰核苷酸、荧光团和添加剂数据库
- 批准号:
7049800 - 财政年份:2006
- 资助金额:
$ 9.75万 - 项目类别:
Manipulating zebrafish genome--conserved helicases
操纵斑马鱼基因组——保守解旋酶
- 批准号:
7084837 - 财政年份:2006
- 资助金额:
$ 9.75万 - 项目类别:
Clinical Validation of ER/PR Test Controls & Calibrators
ER/PR 测试对照的临床验证
- 批准号:
7110811 - 财政年份:2006
- 资助金额:
$ 9.75万 - 项目类别:
PharmacofMRI to Identify New Anxiolytics: A Human Bioassay
PharmacofMRI 鉴定新型抗焦虑药:人体生物测定
- 批准号:
7147829 - 财政年份:2006
- 资助金额:
$ 9.75万 - 项目类别: